$CATX
Perspective Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
$2.46
▲+4.24%+$0.100
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePerspective Therapeutics, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is CATX up today? It is at $2.46 (+4.24%), and our scanner flagged it 109 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CATX spikes, and full due diligence on CATX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CATX 109 times in the last 30 days. Create a free account to track $CATX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CATX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on CATX today, peaking at 6.3x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -167K 0.1% of company | sold 1.5% | 11.27M | $527K at $3.15 | Sep 4, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -81K 0.07% of company | sold 0.7% | 11.44M | $251K at $3.11 | Sep 3, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -42K 0.04% of company | sold 0.4% | 11.52M | $131K at $3.11 | Sep 2, 26 |
Lantheus Holdings, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -36K 0.03% of company | sold 0.3% | 11.56M | $112K at $3.12 | Sep 1, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -36K 0.03% of company | sold 0.3% | 11.56M | $112K at $3.12 | Sep 1, 26 |
Lantheus Holdings, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -78K 0.07% of company | sold 0.7% | 11.60M | $245K at $3.14 | Aug 31, 26 |
Lantheus Alpha Therapy, Llc Beneficial Owner (10%) | Sold (automatic/other) | -78K 0.07% of company | sold 0.7% | 11.60M | $245K at $3.14 | Aug 31, 26 |
Hunt Jonathan Robert Officer | Bought (open market) | +11K | added 23% | 60K | $22K at $2.03 | Nov 13, 25 |
Williamson Robert F Iii Director | Bought (open market) | +9K | added 100% | 10K | $20K at $2.10 | Nov 12, 25 |
Woods Lori A Director | Bought (open market) | +23K 0.02% of company | added 15% | 183K | $50K at $2.13 | Mar 31, 25 |
Williamson Robert F Iii Director | Bought (open market) | +38K 0.03% of company | added 54% | 109K | $82K at $2.14 | Mar 31, 25 |
Graham Juan Officer | Bought (open market) | +33K 0.03% of company | added 100% | 35K | $75K at $2.25 | Mar 28, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
CATX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on CATX today, peaking at 6.3x its normal volume.
CATX last traded at $2.46, up 4.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Perspective Therapeutics, Inc. (CATX) is next expected to report earnings on Monday, November 9, 2026, about 33 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CATX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CATX 109 times in the last 30 days.
CATX (Perspective Therapeutics, Inc.) trades on XASE, with a market cap of about $269M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CATX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CATX discussion
Sign in to ask a question or join the discussion.